At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TMDX TransMedics Group, Inc.
Trading 11-21 13:11:41 EST
80.09
+2.89
+3.74%
High80.64
Low76.60
Vol783.75K
Open77.20
D1 Closing77.20
Amplitude5.23%
Mkt Cap2.69B
Tradable Cap2.61B
Total Shares33.56M
T/O61.78M
T/O Rate2.41%
Tradable Shares32.55M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
TransMedics Group (TMDX) Gets a Buy from Oppenheimer
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.